Oak Hill Bio Launches With Pipeline and Senior Leadership From Takeda
New Company Committed to Developing Life-Changing Medicines for Extremely Preterm Infants and Patients Suffering from Rare Autoimmune Diseases Pipeline Includes Two Programs with Phase 2 Proof-of-Concept
Source: finanznachrichten.de